Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Jin Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4745-9850; OpenAlex author ID A5100782197. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Letter Re: Association of comorbid schizophrenia with cancer stage at admission, treatments, length of stay, and 30-day in-hospital mortality in patients with … First author DOI 10.1016/j.ejca.2025.115734↗
  2. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification. Co-author DOI 10.1007/s00432-022-04400-8↗
  3. Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.tranon.2022.101524↗
  4. Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer. Last author DOI 10.1186/s12885-022-09863-z↗
  5. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy. First author DOI 10.4161/cbt.13.4.18692↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 4 shared papers, 2012–2023 · strength 0.54
  2. Bo Zhang · 3 shared papers, 2022–2023 · strength 0.51
  3. Heyue Zhang · 1 shared paper, 2025 · strength 0.37
  4. Yuanfan Liu · 1 shared paper, 2025 · strength 0.37
  5. Qingcai Meng · 2 shared papers, 2022 · strength 0.30
  6. Miaoyan Wei · 2 shared papers, 2022 · strength 0.30
  7. Jie Hua · 2 shared papers, 2022 · strength 0.30
  8. Siyuan Lu · 2 shared papers, 2022 · strength 0.30
  9. Liang Chen · 1 shared paper, 2023 · strength 0.20
  10. Zhen Tan · 1 shared paper, 2023 · strength 0.20
  11. Quanxing Ni · 1 shared paper, 2012 · strength 0.03
  12. Yongfeng Xu · 1 shared paper, 2012 · strength 0.03
  13. Wenyan Xu · 1 shared paper, 2012 · strength 0.03
  14. Wantong Yao · 1 shared paper, 2012 · strength 0.03
  15. Shunrong Ji · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.